LIVN (STOCKS)
LivaNova PLC Ordinary Shares
$79.700000
+0.310000 (+0.39%)
Prev close: $79.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Vladimir A. Makatsaria
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,378.20M
- Employees
- 2,900
- P/E (TTM)
- 40.98
- P/B (TTM)
- 3.60
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
7
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.98 | $0.91 | +0.0653 | +7.14% |
|
Dec 2025 (Q4)
|
$0.86 | $0.83 | +0.0286 | +3.44% |
|
Sep 2025 (Q3)
|
$1.11 | $0.94 | +0.1726 | +18.41% |
|
Jun 2025 (Q2)
|
$1.05 | $0.87 | +0.1773 | +20.32% |
Financial Statements
| Revenues | $1.43B |
| Benefits Costs and Expenses | $1.31B |
| Cost Of Revenue | $466.09M |
| Costs And Expenses | $1.31B |
| Gross Profit | $967.37M |
| Nonoperating Income/Loss | -$19.79M |
| Operating Expenses | $775.12M |
| Selling, General, and Administrative Expenses | $563.24M |
| Research and Development | $206.58M |
| Other Operating Expenses | $5.31M |
| Operating Income/Loss | $192.24M |
| Income/Loss Before Equity Method Investments | $122.35M |
| Income/Loss From Continuing Operations After Tax | $108.03M |
| Income/Loss From Continuing Operations Before Tax | $122.35M |
| Income/Loss From Equity Method Investments | -$882.00K |
| Income Tax Expense/Benefit | $14.32M |
| Income Tax Expense/Benefit, Deferred | $35.00K |
| Net Income/Loss | $107.15M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $107.15M |
| Net Income/Loss Available To Common Stockholders, Basic | $107.15M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.96 |
| Diluted Earnings Per Share | $1.95 |
| Basic Average Shares | 163,914,000 |
| Diluted Average Shares | 165,824,000 |
| Assets | $2.52B |
| Current Assets | $1.01B |
| Inventory | $165.50M |
| Other Current Assets | $848.73M |
| Noncurrent Assets | $1.50B |
| Fixed Assets | $255.48M |
| Intangible Assets | $224.56M |
| Other Non-current Assets | $1.02B |
| Liabilities | $1.31B |
| Current Liabilities | $762.48M |
| Accounts Payable | $99.15M |
| Other Current Liabilities | $663.33M |
| Noncurrent Liabilities | $542.55M |
| Long-term Debt | $285.30M |
| Other Non-current Liabilities | $257.25M |
| Equity | $1.21B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.21B |
| Liabilities And Equity | $2.52B |
| Net Cash Flow From Operating Activities | $245.59M |
| Net Cash Flow From Operating Activities, Continuing | $245.59M |
| Net Cash Flow From Investing Activities | -$76.86M |
| Net Cash Flow From Investing Activities, Continuing | -$76.86M |
| Net Cash Flow From Financing Activities | -$375.48M |
| Net Cash Flow From Financing Activities, Continuing | -$375.48M |
| Exchange Gains/Losses | $8.03M |
| Net Cash Flow | -$198.73M |
| Net Cash Flow, Continuing | -$206.76M |
| Comprehensive Income/Loss | $146.47M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $146.47M |
| Other Comprehensive Income/Loss | $146.47M |
| Other Comprehensive Income/Loss Attributable To Parent | $39.33M |